➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Last Updated: July 13, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Fasudil

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Fasudil?

Fasudil is an investigational drug.

There have been 10 clinical trials for Fasudil. The most recent clinical trial was a Phase 3 trial, which was initiated on February 1st 2010.

The most common disease conditions in clinical trials are Motor Neuron Disease, Amyotrophic Lateral Sclerosis, and ST Elevation Myocardial Infarction. The leading clinical trial sponsors are Brigham and Women's Hospital, Shahid Beheshti University of Medical Sciences, and Doris Duke Charitable Foundation.

Recent Clinical Trials for Fasudil
Early Intracoronary Administration of Fasudil in the Primary PCI of ST-segment-Elevation Myocardial InfarctionRenJi HospitalPhase 4
Fasudil Eye Drop in Retinopathy Of Prematurity(ROP)Shahid Beheshti University of Medical SciencesPhase 2/Phase 3
Inhibition of Rho Kinase (ROCK) With Fasudil as Disease-modifying Treatment for ALSUniversity Medical Center GoettingenPhase 2

See all Fasudil clinical trials

Clinical Trial Summary for Fasudil

Top disease conditions for Fasudil
Top clinical trial sponsors for Fasudil

See all Fasudil clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.